Trademark: 90862596
Word
CABINET: THE SUSTAINABLE HEALTHCARE COMPANY
Status
Pending
Status Code
688
Status Date
Tuesday, February 20, 2024
Serial Number
90862596
Mark Type
4000
Filing Date
Tuesday, August 3, 2021
Published for Opposition
Tuesday, December 26, 2023

Trademark Owner History
Patel & Gong, Inc. - Owner At Publication

Classifications
41 Providing a website featuring blogs and non-downloadable publications in the nature of magazines, brochures, and articles in the field(s) of pharmaceuticals, medicine, healthcare, disease management, nutrition, diet, fitness, and personal health
9 Downloadable mobile applications for featuring pricing information for prescription drugs and over the counter medications, for purchasing of prescription drugs and over the counter medications, and for providing information regarding health, prescription drugs and over the counter medications; Downloadable mobile applications for use in obtaining prescription and over the counter medications and referrals to healthcare providers; Downloadable software in the nature of a mobile application for use in connection with the collection, analysis, and sharing of personal medical data
5 Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs
35 Retail pharmacy services; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
44 Hygienic and beauty care; Medical services; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing a web site featuring information in the field of mental health and physical health, including living a healthy and disease free life; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks
42 Providing temporary use of on-line non-downloadable software and applications for use in obtaining prescription and over the counter medications and referrals to healthcare providers
"THE SUSTAINABLE HEALTHCARE COMPANY"

Trademark Events
Feb 20, 2024
Noa E-Mailed - Sou Required From Applicant
Dec 26, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 26, 2023
Published For Opposition
Dec 6, 2023
Notification Of Notice Of Publication E-Mailed
Nov 20, 2023
Approved For Pub - Principal Register
May 8, 2023
Notification Of Letter Of Suspension E-Mailed
May 8, 2023
Letter Of Suspension E-Mailed
May 8, 2023
Suspension Letter Written
Apr 20, 2023
Teas/Email Correspondence Entered
Apr 20, 2023
Correspondence Received In Law Office
Apr 19, 2023
Assigned To Lie
Jan 23, 2023
Notice Of Revival - E-Mailed
Jan 22, 2023
Teas Response To Office Action Received
Jan 22, 2023
Petition To Revive-Granted
Jan 22, 2023
Teas Petition To Revive Received
Nov 21, 2022
Abandonment Notice E-Mailed - Failure To Respond
Nov 21, 2022
Abandonment Notice Mailed - Failure To Respond
Nov 21, 2022
Abandonment - Failure To Respond Or Late Response
May 6, 2022
Notification Of Non-Final Action E-Mailed
May 6, 2022
Non-Final Action E-Mailed
May 6, 2022
Non-Final Action Written
Apr 29, 2022
Assigned To Examiner
Sep 28, 2021
New Application Office Supplied Data Entered
Aug 6, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24